相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Extracellular mtDNA activates NF-κB via toll-like receptor 9 and induces cell death in cardiomyocytes
Marte Bliksoen et al.
BASIC RESEARCH IN CARDIOLOGY (2016)
Protective Effects of Ticagrelor on Myocardial Injury After Infarction
Gemma Vilahur et al.
CIRCULATION (2016)
DNA-sensing inflammasomes: regulation of bacterial host defense and the gut microbiota
Si Ming Man et al.
PATHOGENS AND DISEASE (2016)
Ticagrelor Protects the Heart Against Reperfusion Injury and Improves Remodeling After Myocardial Infarction
Yumei Ye et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Mitochondrially targeted Endonuclease III has a powerful anti-infarct effect in an in vivo rat model of myocardial ischemia/reperfusion
Xi-Ming Yang et al.
BASIC RESEARCH IN CARDIOLOGY (2015)
What is Wrong With Cardiac Conditioning? We May be Shooting at Moving Targets
Efstathios K. Iliodromitis et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2015)
Cyclosporine before PCI in Patients with Acute Myocardial Infarction
T. -T. Cung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Meta-Analysis of Randomized Trials of Postconditioning in ST-Elevation Myocardial Infarction
Enrico Favaretto et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Combination of necroptosis and apoptosis inhibition enhances cardioprotection against myocardial ischemia-reperfusion injury
Shizuka Koshinuma et al.
JOURNAL OF ANESTHESIA (2014)
Triple Therapy Greatly Increases Myocardial Salvage During Ischemia/Reperfusion in the in situ Rat Heart
Xi-Ming Yang et al.
CARDIOVASCULAR DRUGS AND THERAPY (2013)
Platelet P2Y12 Blockers Confer Direct Postconditioning-Like Protection in Reperfused Rabbit Hearts
Xi-Ming Yang et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2013)
(S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1β and IL-18
Woods Wannamaker et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Proapoptotic effects of caspase-1/interleukin-converting enzyme dominate in myocardial ischemia
FM Syed et al.
CIRCULATION RESEARCH (2005)
Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1β
BJ Pomerantz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury
MM Mocanu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
分享论文
